TARA
#3521
Protara Therapeutics, Inc. - Common Stock
4.1 7 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.24%
Monthly Change
+5.84%
6 month change
-15.59%
Year Change
+31.13%
Previous Close
4.1 8
Open
4.2 0
Low
4.1 2
High
4.2 1
Volume
88
Financials
- Market Capitalization 234.37 M
- Employee 51
- Founded 2006
- CEO N/A
- Website www.protaratx.com
- Headquarter New York, United States
- FIGI BBG001ZLYSH5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.98
Price to sales ratio
4 659.52
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3479 |  ACIU AC Immune SA - Common Stock | 2.49 USD | +1.63% | -1.19% | +7.79% | +16.90% | 253.34 M USD | ||
| 3518 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.57 USD | +0.85% | -6.05% | -0.56% | -54.92% | 237.88 M USD | ||
| 3528 |  IVVD Invivyd, Inc. - Common Stock | 0.79 USD | 0.00% | -7.06% | -2.47% | +9.72% | 232.74 M USD | ||
| 3542 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.79 USD | -0.79% | -6.65% | -8.01% | +24.67% | 226.95 M USD |
Frequently asked questions about Protara Therapeutics, Inc. - Common Stock
What is the Protara Therapeutics, Inc. - Common Stock stock price today?
The current price of Protara Therapeutics, Inc. - Common Stock (TARA) is 4.17. Over the past 24 hours, the stock has changed by -0.24%. Follow the TARA chart for real-time price dynamics.
What is the stock ticker of Protara Therapeutics, Inc. - Common Stock?
Protara Therapeutics, Inc. - Common Stock trades under the ticker TARA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Protara Therapeutics, Inc. - Common Stock stock going up?
TARA has changed by +1.71% over the last week, +5.84% over the last month, and +31.13% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Protara Therapeutics, Inc. - Common Stock net income for the last quarter?
Protara Therapeutics, Inc. - Common Stock reported net income of -17.78 M for the last quarter. The previous quarter showed -17.31 M, which means net income changed by -2.74%.
How many employees does Protara Therapeutics, Inc. - Common Stock have?
As of the latest available data, Protara Therapeutics, Inc. - Common Stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
What is Protara Therapeutics, Inc. - Common Stock EBITDA?
Protara Therapeutics, Inc. - Common Stock EBITDA is -19.53 M, and its EBITDA margin is -244.14 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Protara Therapeutics, Inc. - Common Stock stock?
You can buy Protara Therapeutics, Inc. - Common Stock (TARA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Protara Therapeutics, Inc. - Common Stock stock?
Investing in Protara Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TARA chart and related analysis on metatrader.com as part of your research.